Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorBodyport Inc.
About this trial
To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.
Eligibility criteria
Qualifiers
Age 21 years or older
Able to speak and read English, or able to speak and read Spanish and has a caregiver or family member who speaks English and can provide assistance
Able to stand on two bare feet unassisted
Receiving automated peritoneal dialysis for the treatment of ESKD
Disqualifiers
Undergoing or plan to undergo hemodialysis in the next 12 months
Have a life expectancy of less than 12 months
Are pregnant or plan to become pregnant during the next 12 months
Weigh greater than 375 lbs
Trial design
Treatments tested in this trial
- Bodyport Cardiac Scale
Treatment groups
125 Participants
are divided into 1 treatment groupLocations
4Canada
Seven Oaks General HospitalR2V 3M3, WinnipegManitoba, Canada
United States
Desert Cities Dialysis92395, VictorvilleCalifornia, United States
Southeastern Clinical Research Institute30904, AugustaGeorgia, United States
Northwestern University60611, ChicagoIllinois, United States
Sponsors and collaborators
Bodyport Inc.
Lead sponsor
Source ClinicalTrials.gov